Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J, Greig J, Hopkins S, Jeyaratnam D, Jenkins N, Llewelyn M, Meisner S, Nsutebu E, Planche T, Read RC, Scarborough M, Soares M, Tilley R, Török ME, Williams J, Wilson P, Wyllie S, Walker AS; United Kingdom Clinical Infection Research Group.

Trials. 2012 Dec 18;13:241. doi: 10.1186/1745-6215-13-241.

PMID:
23249501
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.

Ruotsalainen E, Järvinen A, Koivula I, Kauma H, Rintala E, Lumio J, Kotilainen P, Vaara M, Nikoskelainen J, Valtonen V; Finlevo Study Group.

J Intern Med. 2006 Feb;259(2):179-90.

PMID:
16420547
[PubMed - indexed for MEDLINE]
3.

Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review.

Russell CD, Lawson McLean A, Saunders C, Laurenson IF.

J Med Microbiol. 2014 Jun;63(Pt 6):841-8. doi: 10.1099/jmm.0.072280-0. Epub 2014 Mar 12. Review.

PMID:
24623637
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.

Yzerman EP, Boelens HA, Vogel M, Verbrugh HA.

J Antimicrob Chemother. 1998 Aug;42(2):233-9.

PMID:
9738842
[PubMed - indexed for MEDLINE]
Free Article
5.

A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.

Scawn N, Saul D, Pathak D, Matata B, Kemp I, Stables R, Lane S, Haycox A, Houten R.

Health Technol Assess. 2012 Sep;16(36):i-xiii, 1-70.

PMID:
23010339
[PubMed - indexed for MEDLINE]
Free Article
6.

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.

Goldberg E, Paul M, Talker O, Samra Z, Raskin M, Hazzan R, Leibovici L, Bishara J.

J Antimicrob Chemother. 2010 Aug;65(8):1779-83. doi: 10.1093/jac/dkq179. Epub 2010 May 27.

PMID:
20507860
[PubMed - indexed for MEDLINE]
Free Article
7.

Clinical management of Staphylococcus aureus bacteraemia.

Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, Török ME, Walker S, Wertheim HF, Wilson P, Llewelyn MJ; UK Clinical Infection Research Group.

Lancet Infect Dis. 2011 Mar;11(3):208-22. doi: 10.1016/S1473-3099(10)70285-1. Review.

PMID:
21371655
[PubMed - indexed for MEDLINE]
8.

Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.

Hounsom L, Grayson K, Melzer M.

Postgrad Med J. 2011 Nov;87(1033):757-62. doi: 10.1136/pgmj.2010.116616. Epub 2011 Jul 28.

PMID:
21798969
[PubMed - indexed for MEDLINE]
9.

A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.

Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP; Swiss Staphylococcal Study Group.

Clin Infect Dis. 2004 Nov 1;39(9):1285-92. Epub 2004 Oct 11.

PMID:
15494904
[PubMed - indexed for MEDLINE]
Free Article
10.

[Evaluation of diagnosis and therapy of Staphylococcus aureus bacteraemia: recommended minimum treatment duration of 2 weeks not always met].

Landman GW, Bouwhuis JW, Bloembergen P, van der Meer JT, Groeneveld PH.

Ned Tijdschr Geneeskd. 2011;155(38):A3376. Dutch.

PMID:
21939568
[PubMed - indexed for MEDLINE]
11.

Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand.

Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR, Coombs GW, Murray RJ, Howden B, Johnson PD, Dowling K; Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis.

Med J Aust. 2009 Oct 5;191(7):368-73.

PMID:
19807625
[PubMed - indexed for MEDLINE]
12.

Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.

Gómez J, García-Vázquez E, Baños R, Canteras M, Ruiz J, Baños V, Herrero JA, Valdés M.

Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):239-45.

PMID:
17318479
[PubMed - indexed for MEDLINE]
13.

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.

Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC.

J Antimicrob Chemother. 2011 Oct;66(10):2386-92. doi: 10.1093/jac/dkr301. Epub 2011 Jul 20.

PMID:
21775337
[PubMed - indexed for MEDLINE]
Free Article
14.

Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.

Liu WL, Hung YL, Lin SH, Lee PI, Hsueh PR.

Int J Antimicrob Agents. 2010 Jun;35(6):615-6. doi: 10.1016/j.ijantimicag.2010.02.009. Epub 2010 Mar 16. No abstract available.

PMID:
20236804
[PubMed - indexed for MEDLINE]
15.

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.

Wyllie DH, Crook DW, Peto TE.

BMJ. 2006 Aug 5;333(7562):281. Epub 2006 Jun 23. Erratum in: BMJ. 2006 Sep 2;333(7566):468.

PMID:
16798756
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.

Ho KM, Robinson JO.

Anaesth Intensive Care. 2009 May;37(3):457-63.

PMID:
19499868
[PubMed - indexed for MEDLINE]
17.

A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections.

Khanlari B, Elzi L, Estermann L, Weisser M, Brett W, Grapow M, Battegay M, Widmer AF, Flückiger U.

J Antimicrob Chemother. 2010 Aug;65(8):1799-806. doi: 10.1093/jac/dkq182. Epub 2010 Jun 11.

PMID:
20542908
[PubMed - indexed for MEDLINE]
Free Article
18.

Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.

Riedel DJ, Weekes E, Forrest GN.

Antimicrob Agents Chemother. 2008 Jul;52(7):2463-7. doi: 10.1128/AAC.00300-08. Epub 2008 May 12.

PMID:
18474578
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.

Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA, Corey GR, Abrutyn E.

J Antimicrob Chemother. 2008 Dec;62(6):1413-21. doi: 10.1093/jac/dkn372. Epub 2008 Sep 8.

PMID:
18782781
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk